v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss from continuing operations $ (12,636,410) $ (13,141,074)
Income from discontinued operations 2,684,678
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 518,563 189,869
Amortization of intangible assets 67,015 10,251
Issuance of stock for services 14,803
Amortization of deferred license costs 30,589
Amortization of debt issuance costs and debt discount 1,051,900 611,721
Amortization of right of use asset 866,800
Gain on deconsolidation – SG DevCorp (4,637,013)
Loss on conversion of notes payable 4,915,209
Loss on disposition of equity-based investment 320,408
Change in fair value of equity-based investment 311,560 5,590,666
Stock-based compensation 318,894 1,097,698
Changes in operating assets and liabilities:    
Accounts receivable (93,851) 14,513
Contract assets (45,815) (173,775)
Inventories (39,510) (585,632)
Prepaid expenses and other current assets 100,459 (308,211)
Intangible assets (23,920)
Accounts payable and accrued expenses 2,345,748 881,548
Lease liability (66,821) (1,139,751)
Contract liabilities (324,934) (611,934)
Project development and other assets 111,628
Due from affiliates (366,433)
Net cash used in operating activities by continuing operations (3,817,995) (8,322,569)
Net cash used in operating activities by discontinued operations (1,593,347)
Cash flows from investing activities:    
Cash paid for business combination – Sherman Oil (1,000,000)
Cash paid for business combination – County Line (1,000,000)
Purchase of property, plant and equipment (359,193) (8,007)
Cash received in business combination - NAHD 77,013
Cash received from sale of equity-based investment   125,000
Project development costs (154,089)
Investment in equity method investment (186,000)
Net cash used in investing activities by continuing operations (2,468,180) (37,096)
Net cash used in investing activities by discontinued operations (364,352)
Cash flows from financing activities:    
Repayment of short term notes payable (1,358,376) (5,143,298)
Borrowings on short-term notes payable 3,654,231 8,013,745
Proceeds from warrant inducement 910 494,213
Prefunded warrant exercise 30
Issuance of common stock from EP Agreement 28,867
Issuance of common stock for cash 6,635,294 3,590,386
Net cash provided by financing activities by continuing operations 8,932,059 6,983,943
Net cash provided by financing activities by discontinued operations 3,576,166
Net increase in cash and cash equivalents 2,645,884 242,745
Cash and cash equivalents - beginning of period 375,873 14,212
Cash and cash equivalents - end of period 3,021,757 256,957
Assets and liabilities effected in deconsolidation    
Cash 567,473
Assets held for sale 4,400,361
Prepaid expenses and other current assets 429,331
Property and equipment, net 1,194,117
Project development costs and other assets 91,490
Goodwill 1,810,787
Intangible assets 138,678
Investments in equity-based investments 3,642,607
Accounts payable and accrued expenses 1,600,294
Contingent consideration payable 945,000
Short-term notes payable 6,476,723
Cashless warrant exercise 114
Fractional common share adjustment 1
Common stock deemed dividend – warrant inducement 1,162,436
Common stock deemed dividend – conversion rate change 475,713
Conversion of short-term notes payable to common stock 802,086
Fair value of warrants issued with debt 251,541
Common stock issuance for accounts payable adjustment 1,259,681
Forgiveness of related party debt and investment 2,054,354
Common stock and warrants issued for debt 332,049
Common stock issued for conversion of accrued interest – related party 494,912
Common stock issued for conversion of preferred stock 151,360
Conversions of notes payable to common stock 696,250
Warrant to preferred stock exchange $ 60,000

Source

HTML PDF
XBRL
ZIP